Anatomic Stage II Breast Cancer AJCC v8 Clinical Trials
133 clinical trials for Anatomic Stage II Breast Cancer AJCC v8 across international registries, including 40 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors — RECRUITING · NA
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial — RECRUITING · PHASE3
- Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
- Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer — RECRUITING · PHASE3
- 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss — RECRUITING · PHASE2
- A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer — RECRUITING · NA
- Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer — RECRUITING · NA
- An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial — RECRUITING · PHASE1
- Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab — RECRUITING · PHASE3
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab — RECRUITING · PHASE3
- Breast Cancer, Reasoning, and Activity Intervention — RECRUITING · NA
- Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors — RECRUITING · PHASE2
- Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer — RECRUITING · PHASE1
- Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors — RECRUITING · PHASE2
- Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients — RECRUITING · PHASE2
- Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer — RECRUITING · NA
- Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial — RECRUITING · PHASE2
- Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial — RECRUITING · PHASE2
- Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial — RECRUITING · NA
- Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer — RECRUITING
- Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial — RECRUITING · NA
- Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy — RECRUITING · PHASE3
- DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients — RECRUITING
- Breast Cancer Survivorship Biorepository — RECRUITING
- Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer — RECRUITING · PHASE2
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy — RECRUITING
- Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial — RECRUITING · PHASE3
- A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial — RECRUITING · PHASE2
- Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial — RECRUITING · PHASE2
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
- Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer — RECRUITING
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer — RECRUITING · PHASE1
- Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer — RECRUITING · NA
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — RECRUITING · PHASE1
- The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients — RECRUITING
- Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer — RECRUITING · PHASE2
- Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer — RECRUITING · NA
- Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer — RECRUITING · PHASE3
- Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC — RECRUITING · PHASE2
- Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer — RECRUITING · PHASE2
- Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · NA
- Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Integrative Approaches for Cancer Survivorship (IACS3) — ACTIVE_NOT_RECRUITING · NA
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING
- Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial — NOT_YET_RECRUITING · NA
- STEMVAC in Patients With Early Stage Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden — NOT_YET_RECRUITING · PHASE2
- High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer — SUSPENDED · PHASE2
- CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy — ACTIVE_NOT_RECRUITING · PHASE2
- Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations — TERMINATED · PHASE2
Refine this search